Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Ann Rheum Dis. 2014 Aug 20;74(12):2236–2243. doi: 10.1136/annrheumdis-2014-205799

Figure 5.

Figure 5

Clinical response corresponds to decreased B and T lymphoplasmacytic infiltrate in IgG4-related disease (IgG4-RD) affected tissue. Clinical pictures from a patient with cutaneous IgG4-RD involvement before (A) and after (D) rituximab. H&E, and CD3 stain of skin biopsies before (B and C, respectively) and after (E and F, respectively) treatment with rituximab (original magnification 10×). Immunohistochemistry for IgG4 before (B) and after (E) rituximab is shown in inserts (original magnification 20×).